News J&J files esketamine nasal spray antidepressant in US Drug targets 30% of people who don't respond to approved treatments
News Steve Paul reignites xanomeline research as Karuna CEO Karuna aims to overcome safety concerns with combination therapy
News Online scheme tackles financial difficulties and mental heal... Scheme will be available to NHS customers
News Theresa May's NHS funding pledge insufficient - campaigners Campaigners have said Prime Minister Theresa May’s pledge to boost NHS coffers by £20 billion a year will be insufficient to meet patients' needs, following years of underfunding.<
News Mixed phase 3 results from J&J's esketamine depression drug Drug missed efficacy endpoint in older population
News NI digital "hub" aims to improve youngsters' mental health Hub offers help and advice for young people aged up to 25
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
